Mobile Menu

Round-up: COVID-19 November (Part One)

Keep up to date with all of the latest news and research surrounding the novel coronavirus with your fortnightly COVID-19 round-up.


At the time of writing, there have been:

  • 252,747,753 cases
  • 5,098,225 deaths
  • 228,666,540 recoveries


  • A team of experts has identified 5 of the 29 proteins that make up the COVID-19 virus that are responsible for damaging blood vessels. (Rauti et al, 2021)
  • New data has suggested that some people can clear a nascent SARS-CoV-2 infection so quickly that they never test positive for the virus or produce antibodies against it. (Swadling et al, 2021)
  • Researchers have revealed a strategy for the development of next-generation COVID-19 vaccines. (Burnett et al, 2021)
  • Yale researchers have developed an RNA-based therapy that can protect mice from a range of emerging SARS-CoV-2 variants. (Mao et al, 2021)
  • New research has shown that people with certain sleep disorders have a 31% higher rate of hospitalisation and mortality. (Orbea et al, 2021)
  • Researchers have identified and tested a new antibody that limits the severity of infection against a range of coronaviruses. (Martinez et al, 2021)
  • NIH scientists have identified a mechanism that may influence infectivity of SARS-CoV-2 variants. (Zhang et al, 2021)
  • Oxford researchers have found a gene, LZTFL1, that doubles the risk of dying from COVID-19. (Downes et al, 2021)
  • New research has revealed how both Kappa and Delta variants evade the immune system. (McCallum et al, 2021)

Other news

  • Pfizer recently announced that its novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalisation or death by 89%. (Pfizer, 2021)

More on these topics

Coronavirus / covid-19 / Round-up / Vaccine